The article was originally published on https://sfist.com/2025/10/09/sam-altman-backed-sf-company-making-legal-ecstasy-wins-approval-to-conduct-clinical-trials/An SF-based biotech company is working on a safer, reformulated version of MDMA, better known as ‘molly’ or ‘ecstasy,’ and we’re not tripping when we say they just won FDA approval to begin Phase 1 clinical trials. We have occasionally covered Bay Area medical research into MDMA, the street drug known as “ecstasy” or “molly,” and perhaps a little too enthusiastically at that. But it’s hard to keep our serotonin in check over today’s news in the San Francisco Business Times that a San Francisco based biotech firm called Arcadia Medicine has won approval to conduct clinical trials on a safer and version of MDMA, which in this case, co

See Full Page